Propranolol Extended-Release Capsules Suppliers & Bulk Manufacturers

Available Forms: Extended-Release Capsules

Available Strengths: 60 mg, 80 mg, 120 mg, 160 mg

Reference Brands: Inderal LA®

Category: Antipsychotropic Drugs

Propranolol Extended-Release Capsules is available in Extended-Release Capsules and strengths such as 60 mg, 80 mg, 120 mg, 160 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Propranolol Extended-Release Capsules is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Propranolol Extended-Release Capsules can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Propranolol Extended-Release (ER) capsules are FDA-approved in the U.S. for treating hypertension, angina pectoris, arrhythmias, migraine prophylaxis, and essential tremor. As a non-selective beta-blocker, it is subject to cardiovascular safety labeling, and extended-release formulations must meet modified-release and bioequivalence standards. U.S. regulations require GMP-compliant manufacturing, stability data, and ongoing pharmacovigilance. In the European Union, propranolol ER is authorized for similar indications under national approvals, with adherence to EMA guidance on beta-blockers. EU-specific requirements include Risk Management Plans (RMPs) and post-marketing surveillance. For dossier-ready Propranolol ER capsules, visit Pharmatradz.com.